Page last updated: 2024-10-30

metformin and ACD-MPV

metformin has been researched along with ACD-MPV in 1 studies

Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Rana, U1
Callan, E1
Entringer, B1
Michalkiewicz, T1
Joshi, A1
Parchur, AK1
Teng, RJ1
Konduri, GG1

Other Studies

1 other study available for metformin and ACD-MPV

ArticleYear
AMP-Kinase Dysfunction Alters Notch Ligands to Impair Angiogenesis in Neonatal Pulmonary Hypertension.
    American journal of respiratory cell and molecular biology, 2020, Volume: 62, Issue:6

    Topics: AMP-Activated Protein Kinase Kinases; Animals; Animals, Newborn; Biphenyl Compounds; Ductus Arterios

2020